influenza
major
global
public
health
threat
result
highli
pathogen
variant
larg
zoonot
reservoir
pandem
potenti
metagenom
viral
sequenc
offer
potenti
diagnost
test
influenza
also
provid
insight
transmiss
evolut
drug
resist
simultan
detect
virus
therefor
set
appli
oxford
nanopor
technolog
metagenom
sequenc
respiratori
sampl
gener
influenza
read
limit
detect
genom
copiesml
pool
sampl
observ
strong
relationship
viral
titr
proport
influenza
read
p
appli
method
clinic
throat
swab
gener
influenza
read
sampl
hightomid
viral
titr
cycl
threshold
ct
valu
sampl
low
viral
titr
ct
valu
fals
posit
read
gener
influenzaneg
sampl
thu
nanopor
sequenc
oper
sensit
ci
specif
ci
compar
current
diagnost
standard
coverag
full
length
viru
depend
sampl
composit
neg
influenc
increas
host
bacteri
read
howev
high
influenza
titr
abl
reconstruct
complet
sequenc
eight
gene
segment
also
detect
human
coronaviru
gener
near
complet
human
metapneumoviru
genom
clinic
sampl
optimis
requir
improv
sensit
approach
show
promis
nanopor
platform
use
diagnosi
genet
analysi
influenza
respiratori
virus
influenza
major
global
public
health
threat
result
highli
pathogen
variant
larg
zoonot
reservoir
pandem
potenti
metagenom
viral
sequenc
offer
potenti
diagnost
test
influenza
also
provid
insight
transmiss
evolut
drug
resist
simultan
detect
virus
therefor
set
appli
oxford
nanopor
technolog
metagenom
sequenc
respiratori
sampl
gener
influenza
read
limit
detect
genom
copiesml
pool
sampl
observ
strong
relationship
viral
titr
proport
influenza
read
p
appli
method
clinic
throat
swab
gener
influenza
read
sampl
hightomid
viral
titr
cycl
threshold
ct
valu
sampl
low
viral
titr
ct
valu
fals
posit
read
gener
influenzaneg
sampl
thu
nanopor
sequenc
oper
sensit
ci
specif
ci
compar
current
diagnost
standard
coverag
full
length
viru
depend
sampl
composit
neg
influenc
increas
host
bacteri
read
howev
high
influenza
titr
abl
reconstruct
complet
sequenc
eight
gene
segment
also
detect
human
coronaviru
gener
near
complet
human
metapneumoviru
genom
clinic
sampl
optimis
requir
improv
sensit
approach
show
promis
applic
oxford
nanopor
technolog
ont
http
nanoporetechcom
gener
fulllength
influenza
sequenc
clinic
respiratori
sampl
address
challeng
ont
offer
thirdgener
portabl
realtim
approach
gener
longread
sequenc
data
demonstr
success
across
rang
virus
date
nanopor
sequenc
influenza
report
use
high
titr
viru
vitro
cultur
system
produc
full
length
genom
sequenc
direct
rna
sequenc
target
enrich
either
hybridis
cdna
influenzaspecif
pcr
amplif
therefor
aim
optimis
metagenom
protocol
detect
influenza
virus
directli
clinic
sampl
use
nanopor
sequenc
determin
sensit
compar
exist
diagnost
method
accuraci
compar
shortread
illumina
sequenc
use
clinic
sampl
hospit
patient
influenza
season
sampl
laboratori
control
infect
ferret
first
sequenc
five
influenza
posit
five
influenzaneg
throat
swab
spike
hazara
viru
control
genom
copiesml
use
sispa
approach
follow
nanopor
sequenc
produc
metagenom
data
domin
read
bacteri
origin
extrem
viral
read
detect
pass
sampl
filter
prior
nucleic
acid
extract
increas
detect
viral
read
sever
order
magnitud
fig
filtrat
rel
expens
also
assess
altern
approach
ad
rapid
centrifug
step
pellet
bacteri
human
cell
follow
nucleic
acid
extract
supernat
use
pool
set
influenza
posit
sampl
concentr
genom
copiesml
provid
larg
enough
sampl
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
assess
reproduc
hazara
control
spike
genom
copiesml
enrich
influenza
hazara
similar
filtrat
vs
centrifug
base
read
map
viral
genom
fig
centrifug
simpler
cheaper
select
approach
test
method
optimis
reduc
time
cdna
synthesi
synthesi
tag
randomli
prime
cdna
subsequ
amplif
via
sispa
requir
lengthi
revers
transcript
pcr
step
respect
optimis
stage
upgrad
revers
transcriptas
superscriptiii
superscriptiv
thermofish
reduc
incub
time
process
time
reduct
reduc
pcr
extens
time
within
cycl
process
time
reduct
compar
final
method
origin
protocol
use
triplic
extract
pool
set
influenza
posit
sampl
demonstr
signific
loss
perform
rapid
protocol
fig
adopt
approach
routin
protocol
start
influenza
posit
sampl
pool
genom
copiesml
made
three
volumetr
dilut
seri
use
three
independ
influenzaneg
pool
fig
total
quantiti
cdna
prepar
sequenc
consist
higher
sampl
use
neg
diluent
fig
indic
presenc
higher
concentr
viral
rna
within
like
due
host
cell
lysi
higher
bacteri
presenc
demonstr
variabl
natur
throat
swab
sampl
consist
retriev
hazara
viru
read
three
dilut
seri
nanopor
sequenc
independ
influenza
viru
titr
sampl
fig
sequenc
dilut
seri
gave
consist
proport
total
read
map
hazara
genom
across
dilut
first
two
pool
mean
valu
per
pool
rpm
read
per
million
total
read
standard
deviat
rpm
respect
dilut
seri
gener
rpm
hazara
read
across
sampl
show
decreas
trend
associ
increas
dilut
factor
increasingli
nonvir
rna
introduc
highbackground
pool
limit
influenza
viru
detect
nanopor
pool
sampl
nanopor
sequenc
triplic
sispa
prepar
influenza
posit
pool
produc
mean
rpm
map
influenza
genom
fig
across
dilut
seri
proport
influenza
read
strongli
associ
influenza
viru
titr
pvalu
also
influenc
neg
pool
use
dilut
consist
pattern
observ
hazara
control
sequenc
neg
control
pool
influenza
viru
spike
gener
read
map
influenza
influenza
viru
titr
copiesml
influenza
read
inconsist
detect
across
sampl
fig
suggest
limit
detect
influenza
copiesml
hazara
viru
control
genom
copiesml
spike
genom
coverag
depth
pool
coverag
highbackground
pool
variabl
fig
influenza
genom
coverag
copiesml
segment
sampl
fig
genom
copiesml
influenza
mean
coverag
per
segment
pool
substanti
reduc
highbackground
pool
fig
influenza
titr
copi
ml
coverag
highli
variabl
across
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
genom
segment
howev
present
copiesml
pool
suffici
data
correct
subtyp
tabl
total
read
gener
median
tabl
genexpertneg
sampl
tabl
base
small
dataset
sensit
specif
ci
respect
strong
correl
ct
valu
read
per
sampl
classifi
influenza
rsquar
number
influenza
read
per
million
read
rsquar
fig
detect
control
viru
hazara
genom
copiesml
highli
variabl
demonstr
level
background
nontarget
rna
major
sourc
intersampl
variat
hazara
read
per
sampl
rang
rpm
median
ccbync
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rpm
mean
rpm
tabl
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
data
influenza
diagnost
genom
characteris
whilst
also
detect
sequenc
common
rna
virus
despit
time
reduct
wet
laboratori
process
method
requir
modif
simplifi
acceler
protocol
becom
viabl
neartopati
test
high
error
rate
recognis
concern
nanopor
sequenc
data
crossbarcod
contamin
creat
challeng
low
high
titr
sampl
batch
togeth
avoid
problem
batch
sampl
accord
ct
valu
appli
stringent
barcod
demultiplex
criteria
howev
reduc
total
data
avail
analysi
clinic
diagnost
laboratori
provid
larg
enough
sampl
assess
reproduc
fig
neg
pool
gener
three
pool
throat
swab
sampl
test
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
prior
first
exposur
influenza
day
postinfect
sampl
plaqu
assay
viral
titr
describ
previous
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
